FDA approval for Ingrezza Capsules for the treatment of chorea associated with Huntington’s disease – Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. announced the FDA has approved Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated with Huntington’s disease (HD). Ingrezza is the only selective… read more.
